Glyheal MV 2mg/500mg/0.2mg Tablet SR
Marketer
Docheal Pharma Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glyheal MV 2mg/500mg/0.2mg Tablet SR
Diabetic patients using the anti-diabetic medication, Glyheal MV 2mg/500mg/0.2mg Tablet SR, a combined-therapy formulation, should adhere to their physician's prescribed dosage. This medication effectively manages blood glucose in adult type 2 diabetes mellitus sufferers. Consistent daily ingestion, ideally with meals, maximizes therapeutic efficacy. Dosage adjustments may occur based on individual blood sugar responses. Discontinuing Glyheal MV without medical consultation risks elevated blood glucose, potentially leading to complications like kidney impairment, vision loss, neuropathy, and limb amputation. A comprehensive diabetes management plan, incorporating diet, exercise, and weight management as directed by your doctor, is essential. Hypoglycemia (low blood sugar) is a common side effect; familiarize yourself with symptoms (sweating, dizziness, headache, tremors) and carry a readily available glucose source (e.g., sugary snacks or juice). Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, visual disturbances, fractures, and upper respiratory infections. Weight gain is also possible. Glyheal MV is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before initiating treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are typically recommended.
Primary Ingredients of Glyheal MV 2mg/500mg/0.2mg Tablet SR
The provided text is "undefined," which lacks meaning and cannot be rephrased.
Uses of Glyheal MV 2mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glyheal MV 2mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glyheal MV 2mg/500mg/0.2mg Sustained-Release Tablets should be administered on an empty stomach.
Common Side effects of Glyheal MV 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glyheal MV 2mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glyheal MV 2mg/500mg/0.2mg Tablet SR whole; do not crush, chew, or divide it. Administer this extended-release tablet on an empty stomach.
How Glyheal MV 2mg/500mg/0.2mg Tablet SR works:
Glyheal MV SR tablets (2mg/500mg/0.2mg) contain a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glyheal MV 2mg/500mg/0.2mg SR tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glyheal MV 2mg/500mg/0.2mg sustained-release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glyheal MV 2mg/500mg/0.2mg tablet is likely not safe for use while breastfeeding. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Glyheal MV 2mg/500mg/0.2mg SR tablets pose a likely risk for individuals with kidney impairment and should be omitted. Medical advice is necessary. Moreover, this medication is unsuitable for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glyheal MV 2mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, initiation with a low dose is typical; however, its use is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glyheal MV 2mg/500mg/0.2mg Tablet SR :
Should you forget to take a Glyheal MV 2mg/500mg/0.2mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glyheal MV 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently